Aller au contenu principal

De la revueLSR 2/2022 | p. 69–83La page suivante est la69

Deux arrêts du Tribunal fédéral sur la prescription « off-label » de stupéfiants et psychotropes1

Keywords :
Benzodiazépines ; Off-label ; Stupéfiants ; Substances Psychotropes ; Médicaments ; Autorisation de mise sur le marché

Abstract

The Federal Tribunal recently issued two administrative law judgments regarding physicians who had prescribed substances under control in violation of the rules regarding official notification of off-label prescription (first judgment of May 2021) and in violation of the…
[…]